EP3820461
USE OF ASPARAGINASE IN COMBINATION WITH GSK3A INHIBITION FOR TREATING CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.7.2019EP published:
7.1.2026EP application number:
19833416.1
EPO information:
European Patent Register
Max expiry date:
11.7.2039
Title in English:
USE OF ASPARAGINASE IN COMBINATION WITH GSK3A INHIBITION FOR TREATING CANCERLanguage of the patent:
English
Timeline
Today
12.7.2019EP application
7.1.2026EP Publication
Owner
Name:
The Children's Medical Center CorporationAddress:
55 Shattuck Street, Boston, MA 02115, US
Inventor
Name:
GUTIERREZ, AlejandroAddress:
Boston, MA 02115, US
Name:
HINZE, LauraAddress:
Boston, MA 02115, US
Priority
Number:
201862697053 PDate:
12.7.2018Country:
US
Number:
201862751129 PDate:
26.10.2018Country:
US
Number:
201962839912 PDate:
29.4.2019Country:
US
Classification
Categories:
A61K 38/50, A61K 31/167, A61K 31/415, A61K 31/4015, A61K 31/404, A61K 31/437, A61P 35/00, A61K 31/506, A61K 31/5517, A61K 31/7105, A61K 31/15, A61K 31/5377